TNFSF13B and B-cell chronic lymphocytic leukemia: Menteşe et al. [32] described median soluble BAFF levels of 0.08 ng/mL in CLL patients, whereas median concentrations of 376 ng/mL (ranging from 93 to 8914 ng/mL) and 920 ng/mL (±54 ng/mL) were described by Molica et al. [48] and Haiat et al. [14], respectively.